Please login to the form below

Not currently logged in
Email:
Password:

Celgene hires Thomas Moriarty to lead legal strategy

Joins as general counsel and corporate secretary from Medco Health Solutions

Thomas Moriarty has joined Celgene as general counsel and corporate secretary, a role that will see him  lead global legal strategy at the US biopharma and serve on its management committee.

“Tom Moriarty brings a wealth of experience in global strategic and legal healthcare management,” said Robert Hugin, chair and CEO of Celgene.

“His extensive legal background, as well as his significant leadership experience will provide new insight and valuable perspective on the increasingly complex global healthcare environment.”

This background includes 12 years at Medco Health Solutions from 2000 to 2012, during which he spent his final four years as general counsel and corporate secretary.

Moriarty held several other legal, regulatory, public policy and corporate governance positions at Medco including president, global pharmaceutical strategies; senior VP, pharma strategies and solutions; and senior VP of business development.

Prior to joining Medco, he served as assistant general counsel - pharma and North America for Merial Limited, a Merck & Co and Aventis Company, and as senior attorney for Merck.

9th May 2012

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Main image2
Customers, content and change
By Dominic Tyer...
Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...